{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:02:59Z","timestamp":1750309379934,"version":"3.41.0"},"reference-count":29,"publisher":"Cambridge University Press (CUP)","issue":"10","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Parasitology"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p><jats:italic>Leishmania amazonensis<\/jats:italic>promastigotes are known to express furosemide (Lasix<jats:sup>\u00ae<\/jats:sup>)-sensitive<jats:italic>P<\/jats:italic>-type membrane Na<jats:sup>+<\/jats:sup>-ATPase. In the present study, furosemide activity was studied in intracellular amastigotes and infected BALB\/c mice to investigate its efficacy in cutaneous leishmaniasis (CL). Intracellular parasites, but not macrophages, were found to be sensitive to killing by furosemide (IC<jats:sub>50<\/jats:sub>= 87<jats:italic>\u00b5<\/jats:italic><jats:sc>m<\/jats:sc><jats:italic>vs<\/jats:italic>CC<jats:sub>50<\/jats:sub>\u226b 1000<jats:italic>\u00b5<\/jats:italic><jats:sc>m<\/jats:sc>, respectively). Although furosemide did not induce nitric oxide production or intracellular pH changes in infected macrophages, it led to a significant reactive oxygen species (ROS) burst. Freshly isolated tissue parasites expressed a high degree of Na<jats:sup>+<\/jats:sup>-ATPase activity that decreased with culture, indicative of a higher enzyme expression in amastigotes than in promastigotes. Both intraperitoneal and oral treatment of<jats:italic>L. amazonensis<\/jats:italic>-infected mice with furosemide dosages equivalent to that prescribed as a diuretic significantly reduced the parasite's growth compared with the situation in untreated mice. Combination with oral furosemide increased the efficacy and safety of intraperitoneal treatment with sodium stibogluconate (SSG). To summarize, furosemide control of intracellular leishmanial growth by means of parasite Na<jats:sup>+<\/jats:sup>-ATPase inhibition, and macrophage ROS activation may help explain its sole and SSG-combined therapeutic effect against murine CL.<\/jats:p>","DOI":"10.1017\/s0031182017000695","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T07:17:08Z","timestamp":1496733428000},"page":"1375-1383","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["Anti-parasitic effect of the diuretic and Na<sup>+<\/sup>-ATPAse inhibitor furosemide in cutaneous leishmaniasis"],"prefix":"10.1017","volume":"144","author":[{"given":"N.","family":"ARRUDA-COSTA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"ESCRIVANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. E.","family":"ALMEIDA-AMARAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"MEYER-FERNANDES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"ROSSI-BERGMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"S0031182017000695_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62870-0"},{"key":"S0031182017000695_ref28","first-page":"e3357","article-title":"Production and detection of reactive oxygen species (ROS) in cancers","volume":"57","author":"Wu","year":"2011","journal-title":"Journal of Visualized Experiments"},{"key":"S0031182017000695_ref25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.9.1261"},{"key":"S0031182017000695_ref24","doi-asserted-by":"publisher","DOI":"10.1179\/000349803235002362"},{"key":"S0031182017000695_ref20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-9574LSF"},{"key":"S0031182017000695_ref19","doi-asserted-by":"publisher","DOI":"10.2165\/11596620-000000000-00000"},{"key":"S0031182017000695_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2011.02.007"},{"key":"S0031182017000695_ref16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01023-13"},{"key":"S0031182017000695_ref13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"S0031182017000695_ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003889"},{"key":"S0031182017000695_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(96)40010-2"},{"key":"S0031182017000695_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(03)00382-5"},{"key":"S0031182017000695_ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000242178.44576.b0"},{"key":"S0031182017000695_ref26","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.973850"},{"key":"S0031182017000695_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2007.07.001"},{"key":"S0031182017000695_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2005.03.012"},{"key":"S0031182017000695_ref1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.58.3.779-787.1990","article-title":"Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH","volume":"58","author":"Antoine","year":"1990","journal-title":"Infection and Immunity"},{"key":"S0031182017000695_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2010.07.009"},{"key":"S0031182017000695_ref27","unstructured":"World Health Organization (2012). Research Priorities for Chagas Disease, HAT and Leishmaniasis. WHO Technical Report Series. No. 975. Technical Report of the TDR Disease Reference Group on Chagas Disease, Human African Trypanosomiasis and Leishmaniasis."},{"key":"S0031182017000695_ref23","doi-asserted-by":"publisher","DOI":"10.1038\/315416a0"},{"key":"S0031182017000695_ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135556"},{"key":"S0031182017000695_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.04.025"},{"key":"S0031182017000695_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01505-2"},{"key":"S0031182017000695_ref14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4269\/ajtmh.2007.76.669","article-title":"Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide","volume":"76","author":"Mukbel","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"S0031182017000695_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.03.050"},{"key":"S0031182017000695_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(95)02497-2"},{"key":"S0031182017000695_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03714-6"},{"key":"S0031182017000695_ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015263"},{"key":"S0031182017000695_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12709"}],"container-title":["Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0031182017000695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:11:34Z","timestamp":1750291894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0031182017000695\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0031182017000695"],"URL":"https:\/\/doi.org\/10.1017\/s0031182017000695","relation":{},"ISSN":["0031-1820","1469-8161"],"issn-type":[{"type":"print","value":"0031-1820"},{"type":"electronic","value":"1469-8161"}],"subject":[],"published":{"date-parts":[[2017,6,6]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2017\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}